NEW YORK (GenomeWeb) – Invitae said today that it has acquired health software developer Ommdom and its genomic management tool CancerGene Connect, an end-to-end platform for collecting and managing genetic family histories.

Under the terms of the agreement, Invitae acquired all Ommdom's outstanding capital stock in exchange for approximately $6 million in Invitae common stock.

According to Invitae, the acquisition expands its existing suite of technologies that help patients and clinicians use genetic information as part of mainstream medical care.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.